Silo Pharma, Inc. (SILO) › Shareholders' EquitySilo Pharma, Inc. (SILO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $47.5K2011: -$1.7K2012: -$41.2K2013: $1.79M2016: $846.5K2017: $1.20M2018: $407.4K2019: -$22.9K2020: $1.28M2021: $9.06M2022: $10.34M2023: $6.18M2024: $5.03M2025: $6.31M$6.31M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.31M+25.3%2024$5.03M-18.5%2023$6.18M-40.3%2022$10.34M+14.1%2021$9.06M+607.6%2020$1.28M+5694.5%2019-$22.9K-105.6%2018$407.4K-66.1%2017$1.20M+42.1%2016$846.5K—2013$1.79M+4442.1%2012-$41.2K-2256.6%2011-$1.7K-103.7%2010$47.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share